Semaglutide Injection 4mg/3ml PFS Manufacturer
Our Certifications
WHO-GMPCertified
GMPCertified
ISO 9001:2015Certified
GLPCertified
WHO-GMPCertified
GMPCertified
ISO 9001:2015Certified
GLPCertified
Global Presence
Our products are trusted and supplied across 40+ countries worldwide.
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
Product Overview
Sanjar Pharma manufactures Semaglutide Injection 4mg/3ml in a prefilled syringe format at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured using validated pharmaceutical processes, controlled cleanroom environments, and comprehensive quality systems designed to support product consistency and regulatory compliance.
Semaglutide is a GLP-1 Receptor Agonist widely recognized within the specialty injectable pharmaceutical segment. The prefilled syringe format provides a ready-to-use dosage presentation that supports administration efficiency, dosing accuracy, and streamlined handling across healthcare settings.
Manufactured under strict sterile conditions and supported by advanced analytical testing, microbiological monitoring, and quality assurance systems, Sanjar Pharma supplies Semaglutide Injection to pharmaceutical companies, distributors, healthcare institutions, procurement agencies, and international pharmaceutical markets.
Technical Specifications
| Generic Name | Semaglutide |
|---|---|
| Strength | 4mg/3ml |
| Brand Name | SP-TIDE |
| Therapeutic Category | Antidiabetic Agent |
| Dosage Form | Prefilled Syringe (PFS) |
| Route of Administration | Subcutaneous Injection |
| Product Type | Sterile Injectable |
| Manufacturing Standard | WHO-GMP |
| Supply Type | Commercial Supply |
| Contract Manufacturing | Available |
| Third Party Manufacturing | Available |
| Regulatory Documentation | Available Upon Request |
| Storage Condition | As Per Approved Product Specifications |
| Export Supply | Available |
Advanced Pharmaceutical Manufacturing Infrastructure
Sanjar Pharma operates a WHO-GMP compliant sterile injectable facility equipped with modern production technologies, quality assurance systems, analytical laboratories, and microbiological testing capabilities designed to support specialty pharmaceutical manufacturing.
Why Choose Sanjar Pharma for Semaglutide Manufacturing
-
Expertise in Sterile Injectable Manufacturing
-
WHO-GMP Certified Pharmaceutical Facility
-
Advanced Quality Control Systems
-
Comprehensive Microbiology Testing Programs
-
Specialty Pharmaceutical Manufacturing Capabilities
-
Export-Oriented Pharmaceutical Operations
-
Contract Manufacturing Support
-
Third Party Manufacturing Solutions
Industries We Serve
Enquire About This Product
Submit your requirement parameters below for rapid commercial export handling.
